Nesina

Takeda Pharmaceuticals struggles to gain FDA approval

Takeda Pharmaceuticals determined to gain FDA drug approval

  • Mon, 05/14/2012 - 1:48pm

In a country bulging with 23 million people with type 2 diabetes, Avandia and its successor, Actos, were once blockbuster drugs in the U.S.

Pages

Brought to you by Spangenberg Shibley & Liber, LLP © 2012